A non-sense mutation at Arg95 is predominant in complement 9 deficiency in Japanese

Takahiko Horiuchi, Hiroaki Nishizaka, Takeshi Kojima, Takuya Sawabe, Yoshiyuki Niho, Peter M. Schneider, Shoichi Inaba, Kouko Sakai, Kenshi Hayashi, Chinami Hashimura, Yasuo Fukumori

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Deficiency of the ninth component of complement (C9D) is one of the most common genetic abnormalities in Japan, with an incidence of one homozygote in 1000. Although C9D individuals are usually healthy, it has been shown that they have an significantly increased risk of developing meningococcal meningitis. In the present study we report the molecular bases for C9D in 10 unrelated Japanese subjects. As a screening step for mutations, exons 2 to 11 of the C9 gene were analyzed using exon-specific PCR/single-strand conformation polymorphism analysis, which demonstrated aberrantly migrating DNA bands in exon 4 in all the C9D subjects. Subsequent direct sequencing of exon 4 of the C9D subjects revealed that eight of the 10 C9D subjects were homozygous for a C to T transition at nucleotide 343, the first nucleotide of the codon CGA for Arg95, leading to a TGA stop codon (R95X). R95X is a novel mutation different from those recently identified in a Swiss family with C9D. Cases 6 and 7 were heterozygous for the R95X mutation. Family study in case 10 confirmed the genetic nature of the defect. In case 6, the second mutation for C9D of the C9 gene was identified to be the substitution of Cys to Tyr at amino acid residue 507 (C507Y), while the genetic defect(s) in the other allele in case 7 remains unknown. Our results indicate that a novel mutation, R95X, is present in most cases of C9D in Japan.

Original languageEnglish
Pages (from-to)1509-1513
Number of pages5
JournalJournal of Immunology
Volume160
Issue number3
Publication statusPublished - Feb 1 1998

Fingerprint

Complement C9
Exons
Mutation
Terminator Codon
Japan
Nucleotides
Meningococcal Meningitis
Homozygote
Codon
Genes
Alleles
Amino Acids
Polymerase Chain Reaction
DNA
Incidence

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Horiuchi, T., Nishizaka, H., Kojima, T., Sawabe, T., Niho, Y., Schneider, P. M., ... Fukumori, Y. (1998). A non-sense mutation at Arg95 is predominant in complement 9 deficiency in Japanese. Journal of Immunology, 160(3), 1509-1513.

A non-sense mutation at Arg95 is predominant in complement 9 deficiency in Japanese. / Horiuchi, Takahiko; Nishizaka, Hiroaki; Kojima, Takeshi; Sawabe, Takuya; Niho, Yoshiyuki; Schneider, Peter M.; Inaba, Shoichi; Sakai, Kouko; Hayashi, Kenshi; Hashimura, Chinami; Fukumori, Yasuo.

In: Journal of Immunology, Vol. 160, No. 3, 01.02.1998, p. 1509-1513.

Research output: Contribution to journalArticle

Horiuchi, T, Nishizaka, H, Kojima, T, Sawabe, T, Niho, Y, Schneider, PM, Inaba, S, Sakai, K, Hayashi, K, Hashimura, C & Fukumori, Y 1998, 'A non-sense mutation at Arg95 is predominant in complement 9 deficiency in Japanese', Journal of Immunology, vol. 160, no. 3, pp. 1509-1513.
Horiuchi T, Nishizaka H, Kojima T, Sawabe T, Niho Y, Schneider PM et al. A non-sense mutation at Arg95 is predominant in complement 9 deficiency in Japanese. Journal of Immunology. 1998 Feb 1;160(3):1509-1513.
Horiuchi, Takahiko ; Nishizaka, Hiroaki ; Kojima, Takeshi ; Sawabe, Takuya ; Niho, Yoshiyuki ; Schneider, Peter M. ; Inaba, Shoichi ; Sakai, Kouko ; Hayashi, Kenshi ; Hashimura, Chinami ; Fukumori, Yasuo. / A non-sense mutation at Arg95 is predominant in complement 9 deficiency in Japanese. In: Journal of Immunology. 1998 ; Vol. 160, No. 3. pp. 1509-1513.
@article{41b09dda9fd541b38f3e1eef6262b2b0,
title = "A non-sense mutation at Arg95 is predominant in complement 9 deficiency in Japanese",
abstract = "Deficiency of the ninth component of complement (C9D) is one of the most common genetic abnormalities in Japan, with an incidence of one homozygote in 1000. Although C9D individuals are usually healthy, it has been shown that they have an significantly increased risk of developing meningococcal meningitis. In the present study we report the molecular bases for C9D in 10 unrelated Japanese subjects. As a screening step for mutations, exons 2 to 11 of the C9 gene were analyzed using exon-specific PCR/single-strand conformation polymorphism analysis, which demonstrated aberrantly migrating DNA bands in exon 4 in all the C9D subjects. Subsequent direct sequencing of exon 4 of the C9D subjects revealed that eight of the 10 C9D subjects were homozygous for a C to T transition at nucleotide 343, the first nucleotide of the codon CGA for Arg95, leading to a TGA stop codon (R95X). R95X is a novel mutation different from those recently identified in a Swiss family with C9D. Cases 6 and 7 were heterozygous for the R95X mutation. Family study in case 10 confirmed the genetic nature of the defect. In case 6, the second mutation for C9D of the C9 gene was identified to be the substitution of Cys to Tyr at amino acid residue 507 (C507Y), while the genetic defect(s) in the other allele in case 7 remains unknown. Our results indicate that a novel mutation, R95X, is present in most cases of C9D in Japan.",
author = "Takahiko Horiuchi and Hiroaki Nishizaka and Takeshi Kojima and Takuya Sawabe and Yoshiyuki Niho and Schneider, {Peter M.} and Shoichi Inaba and Kouko Sakai and Kenshi Hayashi and Chinami Hashimura and Yasuo Fukumori",
year = "1998",
month = "2",
day = "1",
language = "English",
volume = "160",
pages = "1509--1513",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "3",

}

TY - JOUR

T1 - A non-sense mutation at Arg95 is predominant in complement 9 deficiency in Japanese

AU - Horiuchi, Takahiko

AU - Nishizaka, Hiroaki

AU - Kojima, Takeshi

AU - Sawabe, Takuya

AU - Niho, Yoshiyuki

AU - Schneider, Peter M.

AU - Inaba, Shoichi

AU - Sakai, Kouko

AU - Hayashi, Kenshi

AU - Hashimura, Chinami

AU - Fukumori, Yasuo

PY - 1998/2/1

Y1 - 1998/2/1

N2 - Deficiency of the ninth component of complement (C9D) is one of the most common genetic abnormalities in Japan, with an incidence of one homozygote in 1000. Although C9D individuals are usually healthy, it has been shown that they have an significantly increased risk of developing meningococcal meningitis. In the present study we report the molecular bases for C9D in 10 unrelated Japanese subjects. As a screening step for mutations, exons 2 to 11 of the C9 gene were analyzed using exon-specific PCR/single-strand conformation polymorphism analysis, which demonstrated aberrantly migrating DNA bands in exon 4 in all the C9D subjects. Subsequent direct sequencing of exon 4 of the C9D subjects revealed that eight of the 10 C9D subjects were homozygous for a C to T transition at nucleotide 343, the first nucleotide of the codon CGA for Arg95, leading to a TGA stop codon (R95X). R95X is a novel mutation different from those recently identified in a Swiss family with C9D. Cases 6 and 7 were heterozygous for the R95X mutation. Family study in case 10 confirmed the genetic nature of the defect. In case 6, the second mutation for C9D of the C9 gene was identified to be the substitution of Cys to Tyr at amino acid residue 507 (C507Y), while the genetic defect(s) in the other allele in case 7 remains unknown. Our results indicate that a novel mutation, R95X, is present in most cases of C9D in Japan.

AB - Deficiency of the ninth component of complement (C9D) is one of the most common genetic abnormalities in Japan, with an incidence of one homozygote in 1000. Although C9D individuals are usually healthy, it has been shown that they have an significantly increased risk of developing meningococcal meningitis. In the present study we report the molecular bases for C9D in 10 unrelated Japanese subjects. As a screening step for mutations, exons 2 to 11 of the C9 gene were analyzed using exon-specific PCR/single-strand conformation polymorphism analysis, which demonstrated aberrantly migrating DNA bands in exon 4 in all the C9D subjects. Subsequent direct sequencing of exon 4 of the C9D subjects revealed that eight of the 10 C9D subjects were homozygous for a C to T transition at nucleotide 343, the first nucleotide of the codon CGA for Arg95, leading to a TGA stop codon (R95X). R95X is a novel mutation different from those recently identified in a Swiss family with C9D. Cases 6 and 7 were heterozygous for the R95X mutation. Family study in case 10 confirmed the genetic nature of the defect. In case 6, the second mutation for C9D of the C9 gene was identified to be the substitution of Cys to Tyr at amino acid residue 507 (C507Y), while the genetic defect(s) in the other allele in case 7 remains unknown. Our results indicate that a novel mutation, R95X, is present in most cases of C9D in Japan.

UR - http://www.scopus.com/inward/record.url?scp=0031941575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031941575&partnerID=8YFLogxK

M3 - Article

VL - 160

SP - 1509

EP - 1513

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 3

ER -